SF-PL/siGPC3 with selected sizes and zeta potentials, delivered by PEI-modified liposomes, was shown to accumulate at the tumor site and to enter HCC cells, resulting in suppression of both GPC3 and the pro-proliferation gene cyclin D1 expression a. The gene discussed is GPC3; the disease is neoplasm.